CIK 0001678660
- Non-accelerated filer
- Smaller reporting company
Prelude Therapeutics Inc
Sign in to watch- Ticker
- PRLD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811384762
- Phone
- +1 302-467-1280
- Business address
- 175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
- Former names
- Prelude Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Conversion | +45,524 | 766,245 | ||
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Conversion | +574,327 | 7,773,444 | ||
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Purchase | +104,628 | $19.00 | $2.0M | 870,873 |
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Purchase | +1,474,319 | $19.00 | $28.0M | 9,247,763 |
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Conversion · Series A Convertible Preferred Stock | −329,478 | 0 | ||
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Conversion · Series A Convertible Preferred Stock | −2,965,263 | 0 | ||
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Conversion · Series A Convertible Preferred Stock | −219,653 | 0 | ||
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Conversion · Non-Voting Common Stock | +219,653 | 219,653 | ||
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Conversion · Series A Convertible Preferred Stock | −1,976,841 | 0 | ||
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Conversion · Non-Voting Common Stock | +1,976,841 | 1,976,841 | ||
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Conversion · Series B Convertible Preferred Stock | −370,552 | 0 | ||
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Conversion · Series B Convertible Preferred Stock | −4,047,634 | 0 | ||
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Conversion · Series B Convertible Preferred Stock | −247,034 | 0 | ||
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Conversion · Non-Voting Common Stock | +247,034 | 466,687 | ||
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Conversion · Series B Convertible Preferred Stock | −2,698,424 | 0 | ||
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Conversion · Non-Voting Common Stock | +2,698,424 | 4,675,265 | ||
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Conversion · Series C Convertible Preferred Stock | −45,524 | 0 | ||
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Conversion · Series C Convertible Preferred Stock | −574,327 | 0 | ||
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Conversion · Series C Convertible Preferred Stock | −30,349 | 0 | ||
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Conversion · Non-Voting Common Stock | +30,349 | 497,036 |
Page 16 of 19 · 369 trades